CAS 1094-61-7 Beta Nicotinamide Mononucleotide Nmn Powder C11h15n2o8p

Nmn Powder CAS 1094-61-7 Beta Nicotinamide Mononucleotide Nmn Capsules

Beta-nicotinamide Mononucleotide (NMN), a product of the NAMPT reaction and a key NAD+ intermediate, ameliorates glucose intolerance by restoring NAD+ levels in HFD-induced T2D mice. NMN also enhances hepatic sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation. NMN is used for studying binding motifs within RNA aptamers and ribozyme activation processes involving β-nicotinamide mononucleotide (Beta-NMN)-activated RNA fragments.
Nicotinamide mononucleotide ("NMN" and "β-NMN") is a nucleotide derived from ribose and nicotinamide. Niacinamide (nicotinamide,) is a form of vitamin B3 (niacin.) As a biochemical precursor of NAD+, it may be useful in the prevention of pellagra.
Its unconcentrated form, niacin, is found in a variety of nutritional sources: Peanuts, Mushrooms (portobello, grilled), Avocados, Green Peas (fresh), and certain fish and animal meats.
In studies [on mice], NMN has shown to reverse age-related arterial dysfunction by decreasing oxidative stress.

Nicotinamide Mononucleotide cas 1094-61-7

Product Name: NMN Nicotinamide Mononucleotide
Specification: 99% HPLC
Appearance: White Powder

1. NMN can prevent pathological changes of skin and diseases of alimentary canal, such as dermatitis, black tongue, vomiting and diarrhea etc.
2. By participating in material and energy metabolism, NMN can promote the body growth.
3. By combining with other medicines, NMN can cure catarrh and ulcer.
4. By improving the ability of blood supply with strong expansion function of blood vessel, NMN is highly effective in curing such diseases as dermatosis, hypercholesterolemia disease and coronary heart disease.